176 related articles for article (PubMed ID: 2823400)
21. [The clinico-diagnostic and therapeutic considerations in carcinoma of the male breast].
Martino G; Corbelli GC; Pascarella G; Zelli GP
G Chir; 1993 Jan; 14(1):45-50. PubMed ID: 8386929
[TBL] [Abstract][Full Text] [Related]
22. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
[TBL] [Abstract][Full Text] [Related]
23. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.
Petit JY; Veronesi U; Orecchia R; Luini A; Rey P; Intra M; Didier F; Martella S; Rietjens M; Garusi C; DeLorenzi F; Gatti G; Leon ME; Casadio C
Breast Cancer Res Treat; 2006 Mar; 96(1):47-51. PubMed ID: 16261402
[TBL] [Abstract][Full Text] [Related]
24. Residual breast cancer at a distance from the primary tumor.
Singer JA
Am Surg; 1993 Jul; 59(7):435-7. PubMed ID: 8391770
[TBL] [Abstract][Full Text] [Related]
25. [The consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999].
Schwartz GF; Solin LJ; Olivotto IA; Ernster VL;
Bull Cancer; 2000 Jun; 87(6):499-506. PubMed ID: 10903791
[No Abstract] [Full Text] [Related]
26. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
27. Induction of epithelial abnormalities that resemble human breast lesions by the expression of the neu/erbB-2 oncogene in reconstituted mouse mammary gland.
Bradbury JM; Arno J; Edwards PA
Oncogene; 1993 Jun; 8(6):1551-8. PubMed ID: 8099220
[TBL] [Abstract][Full Text] [Related]
28. Late recurrence of ductal carcinoma in situ at the cutaneous end of surgical drainage following total mastectomy.
Finkelstein SD; Sayegh R; Thompson WR
Am Surg; 1993 Jul; 59(7):410-4. PubMed ID: 8391769
[TBL] [Abstract][Full Text] [Related]
29. Prospective study of wide excision alone for ductal carcinoma in situ of the breast.
Lagios MD; Page DL; Silverstein MJ
J Clin Oncol; 2006 Aug; 24(23):3809-11; author reply 3811-2. PubMed ID: 16896011
[No Abstract] [Full Text] [Related]
30. Influence of age on induction of mammary tumors by diethylstilbestrol in C3H/HeN mice with low murine mammary tumor virus titer.
Greenman DL; Highman B; Chen JJ; Schieferstein GJ; Norvell MJ
J Natl Cancer Inst; 1986 Oct; 77(4):891-8. PubMed ID: 3020299
[TBL] [Abstract][Full Text] [Related]
31. Development and characterization of the BALB/cNIV mouse strain.
Young LJ; DeOme KB; Blair PB; Pitelka DR; Cardiff RD
Cancer Res; 1984 Oct; 44(10):4333-6. PubMed ID: 6088036
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer-specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast.
Lee LA; Silverstein MJ; Chung CT; Macdonald H; Sanghavi P; Epstein M; Holmes DR; Silberman H; Ye W; Lagios MD
Am J Surg; 2006 Oct; 192(4):416-9. PubMed ID: 16978940
[TBL] [Abstract][Full Text] [Related]
33. Lack of Thy 1.2 antigen expression on the surfaces of mouse mammary epithelial cells.
Thompson K
J Natl Cancer Inst; 1981 Jul; 67(1):143-8. PubMed ID: 6265679
[TBL] [Abstract][Full Text] [Related]
34. Cryosurgery in the treatment of basal cell carcinoma. Assessment of one and two freeze-thaw cycle schedules.
Mallon E; Dawber R
Dermatol Surg; 1996 Oct; 22(10):854-8. PubMed ID: 9246168
[TBL] [Abstract][Full Text] [Related]
35. Ductal carcinoma in situ of the breast.
Brown AP
N Engl J Med; 2004 Jul; 351(4):399-402; author reply 399-402. PubMed ID: 15269325
[No Abstract] [Full Text] [Related]
36. DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.
Sautter-Bihl ML; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sedlmayer F; Souchon R; Wenz F; Sauer R; ;
Strahlenther Onkol; 2007 Dec; 183(12):661-6. PubMed ID: 18040609
[TBL] [Abstract][Full Text] [Related]
37. Local recurrences after conservative treatment of ductal carcinoma-in-situ of the breast without radiotherapy: the effect of age.
Schouten van der Velden AP; Peeters PH; Koot VC; Hennipman A
Ann Surg Oncol; 2006 Jul; 13(7):990-8. PubMed ID: 16788762
[TBL] [Abstract][Full Text] [Related]
38. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.
Hiramatsu H; Bornstein BA; Recht A; Schnitt SJ; Baum JK; Connolly JL; Duda RB; Guidi AJ; Kaelin CM; Silver EB; Harris JR
Cancer J Sci Am; 1995; 1(1):55-61. PubMed ID: 9166455
[TBL] [Abstract][Full Text] [Related]
39. Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer.
Walser TC; Rifat S; Ma X; Kundu N; Ward C; Goloubeva O; Johnson MG; Medina JC; Collins TL; Fulton AM
Cancer Res; 2006 Aug; 66(15):7701-7. PubMed ID: 16885372
[TBL] [Abstract][Full Text] [Related]
40. A prospective study of conservative surgery without radiation therapy in select patients with Stage I breast cancer.
Lim M; Bellon JR; Gelman R; Silver B; Recht A; Schnitt SJ; Harris JR
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1149-54. PubMed ID: 16750330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
